Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer-Reference-Cited by-同舟云学术

Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer

Published:2016-08 Issue: Volume:164 Page:152-169
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Wigerup Caroline,Påhlman Sven,Bexell Daniel

Funder

Berta Kamprad Foundation

Swedish Cancer Society

Swedish Childhood Cancer Foundation

Swedish Research Council, VINNOVA

SSF Strategic Center for Translational Cancer Research-CREATE Health

Strategic Cancer Research Program BioCARE

Crafoord Foundation

The Royal Physiographic Society in Lund

Gunnar Nilsson's Cancer Foundation

Hans von Kantzows' Foundation

Jeanssons Stiftelser

The Krapperup Foundation

Region Skåne and Skåne University Hospital research funds

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference289 articles.

1. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer;Aebersold;Cancer Res,2001

2. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas;Amar;J Clin Endocrinol Metab,2007

3. The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression;Amelio;Trends Biochem Sci,2015

4. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha;An;Nature,1998

5. Immunity, inflammation and cancer: a leading role for adenosine;Antonioli;Nat Rev Cancer,2013

Cited by 493 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of the HIF switch in human endothelial and cancer cells;European Journal of Cell Biology;2024-06

2. Tumor associated carbonic anhydrase inhibitors: Rational approaches, design strategies, structure activity relationship and mechanistic insights;European Journal of Medicinal Chemistry Reports;2024-04

3. The Role of the PTEN Tumor Suppressor Gene and Its Anti-Angiogenic Activity in Melanoma and Other Cancers;Molecules;2024-02-04

4. Exposure of human glioblastoma cells to thimerosal inhibits the thioredoxin system and decreases tumor growth-related factors;Toxicology and Applied Pharmacology;2024-02

5. Azo-based hypoxic-activated 6-diazo-5-oxo-L-norleucine (DON) prodrug combined with vascular disrupting agent nanoparticles for tumor-selective glutamine metabolism blockade;Chemical Engineering Journal;2024-02